Tag: biotechnology
Sector ETF Spotlight: $IBB Biotechnology on Drugs
Biotechnology has traded basically sideways since the start of 2023.
In the face of higher rates, stronger dollar, inflation, FDA approvals and busts, and an...
Recent Buying In Biotech Sector Could Benefit Newer Companies
With companies like Pfizer (PFE) giving possible hope for an end of year vaccine and a recent gap up in Nasdaq Biotechnology ETF (IBB),...
Biotech Sector ETF Breaks Price Support, Downside Target In View
The biotechnology industry appears to have completed a transition from accumulation to consolidation to distribution.
A confluence of price support levels around $125 for the...
The Beauty of the Biotechnology ETF (IBB) Price Channel
If there is one area to watch should the stock market have another run up, it is the Biotechnology Sector NASDAQ: IBB.
The channel lines...
Big Brother Biotechnology Sector ETF (IBB): How Big is Big?
Today, the ETF that holds Biogen, Regeneron, Amgen, Gilead as four of the top ten in its basket, sits near the low price from...
Biotech ETF (XBI) On The Brink Of A Breakout
The volatility in the biotech space over the last two years has been quite a sight to behold.
I’m not strictly speaking of volatility in...
Biotechnology Sector Testing Bull Market Trendline
When this market cycle finally comes to an end, among the sectors that will be remembered as one of its key drivers is biotechnology....
What’s Next For Biotech Stocks? Watch This Trend Line
There has been a lot of buzz surrounding the recent weakness in the Biotech stocks as traders try to digest the recent bouts of selling...
Why The Biotech Sector ETF (IBB) Is “Distributing” Pain
A few days ago I tweeted that the iShares Nasdaq Biotechnology ETF (IBB) looked to have entered a period of clear “distribution”, meaning that...
The Amazing Run In Biotech Stocks
Biotech stocks have been on fire in 2015. In the Biotech & Pharmaceuticals sector of the Russell 2000 Growth Index, there are over sixty...
